The landscape of GWAS validation; systematic review identifying 309 validated non-coding variants across 130 human diseases

AJ Alsheikh, S Wollenhaupt, EA King, J Reeb… - BMC medical …, 2022 - Springer
Background The remarkable growth of genome-wide association studies (GWAS) has
created a critical need to experimentally validate the disease-associated variants, 90% of …

Regulatory SNPs: altered transcription factor binding sites implicated in complex traits and diseases

AO Degtyareva, EV Antontseva… - International journal of …, 2021 - mdpi.com
The vast majority of the genetic variants (mainly SNPs) associated with various human traits
and diseases map to a noncoding part of the genome and are enriched in its regulatory …

Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants

KG Aragam, T Jiang, A Goel, S Kanoni, BN Wolford… - Nature …, 2022 - nature.com
The discovery of genetic loci associated with complex diseases has outpaced the
elucidation of mechanisms of disease pathogenesis. Here we conducted a genome-wide …

Histone deacetylase 9 activates IKK to regulate atherosclerotic plaque vulnerability

Y Asare, TA Campbell-James, Y Bokov, LL Yu… - Circulation …, 2020 - Am Heart Assoc
Rationale: Arterial inflammation manifested as atherosclerosis is the leading cause of
mortality worldwide. Genome-wide association studies have identified a prominent role of …

[HTML][HTML] Stroke by inducing HDAC9-dependent deacetylation of HIF-1 and Sp1, promotes TfR1 transcription and GPX4 reduction, thus determining ferroptotic neuronal …

L Sanguigno, N Guida, S Anzilotti… - … journal of biological …, 2023 - ncbi.nlm.nih.gov
Background: The inhibition of histone deacetylase 9 (HDAC9) represents a promising
druggable target for stroke intervention. Indeed, HDAC9 is overexpressed in neurons after …

Histone deacetylases (HDACs) and atherosclerosis: A mechanistic and pharmacological review

X Chen, Y He, W Fu, A Sahebkar, Y Tan… - Frontiers in Cell and …, 2020 - frontiersin.org
Atherosclerosis (AS), the most common underlying pathology for coronary artery disease, is
a chronic inflammatory, proliferative disease in large-and medium-sized arteries. The …

Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer

C Yang, S Croteau, P Hardy - Cellular Oncology, 2021 - Springer
Abstract Background HDAC9 (histone deacetylase 9) belongs to the class IIa family of
histone deacetylases. This enzyme can shuttle freely between the nucleus and cytoplasm …

Hdac9 inhibition as a novel treatment for stroke

HS Markus - Stroke, 2023 - Am Heart Assoc
The identification of a variant in the HDAC9 gene as a risk factor for large-artery
atherosclerotic stroke, and subsequently coronary artery disease, has opened novel …

[HTML][HTML] Epigenetics and microRNAs in cardiovascular diseases

RMW Colpaert, M Calore - Genomics, 2021 - Elsevier
Cardiovascular diseases are among the leading causes of mortality worldwide. Besides
environmental and genetic changes, these disorders can be influenced by processes which …

New insight in HDACs: Potential therapeutic targets for the treatment of atherosclerosis

Y Luan, H Liu, Y Luan, Y Yang, J Yang… - Frontiers in …, 2022 - frontiersin.org
Atherosclerosis (AS) features include progressive hardening and reduced elasticity of
arteries. AS is the leading cause of morbidity and mortality. An increasing amount of …